Scarica l'app Stockscreener
0.7304
1.05%
0.0076
Dopo l'orario di chiusura:
.73
-0.0004
-0.05%
Precedente Chiudi:
$0.7228
Aprire:
$0.7365
Volume 24 ore:
51,757
Relative Volume:
0.43
Capitalizzazione di mercato:
$5.44M
Reddito:
-
Utile/perdita netta:
$-16.28M
Rapporto P/E:
-0.0525
EPS:
-13.91
Flusso di cassa netto:
$-13.75M
1 W Prestazione:
-7.54%
1M Prestazione:
-1.85%
6M Prestazione:
-46.69%
1 anno Prestazione:
-81.56%
Intervallo 1D:
$0.7063
$0.7399
Intervallo di 1 settimana:
$0.70
$0.791
Portata 52W:
$0.65
$4.5706
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Nome
Pasithea Therapeutics Corp
Settore
Industria
Telefono
(702) 514-4174
Indirizzo
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Confronta KTTA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.7304 | 5.48M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pasithea Therapeutics Corp Borsa (KTTA) Ultime notizie
Pasithea Therapeutics Corp. Equity Warrant stock trend forecastWeekly Trading Summary & Verified Momentum Watchlists - newser.com
Understanding Pasithea Therapeutics Corp. Equity Warrant’s price movementMarket Sentiment Summary & Risk Controlled Stock Pick Alerts - newser.com
Has Pasithea Therapeutics Corp. formed a bullish divergenceWeekly Market Report & Growth Focused Stock Pick Reports - newser.com
Using data tools to time your Pasithea Therapeutics Corp. Equity Warrant exitLong Setup & Real-Time Buy Signal Notifications - newser.com
Published on: 2025-10-15 11:50:55 - newser.com
How Pasithea Therapeutics Corp. stock performs in interest rate cyclesPortfolio Growth Summary & Community Supported Trade Ideas - newser.com
Can swing trading help recover from Pasithea Therapeutics Corp. lossesQuarterly Market Review & Trade Opportunity Analysis - newser.com
Can technical indicators confirm Pasithea Therapeutics Corp. Equity Warrant’s reversalEarnings Overview Summary & Weekly Sector Rotation Insights - newser.com
Can swing trading help recover from Pasithea Therapeutics Corp. Equity Warrant lossesProfit Target & Stepwise Entry/Exit Trade Alerts - newser.com
Is Pasithea Therapeutics Corp. stock a dividend growth opportunity2025 Key Highlights & Reliable Price Breakout Signals - newser.com
Pasithea Therapeutics (NASDAQ:KTTA) Receives Sell (E) Rating from Weiss Ratings - Defense World
Chart based exit strategy for Pasithea Therapeutics Corp.Exit Point & Safe Entry Trade Signal Reports - newser.com
Institutional scanner results for Pasithea Therapeutics Corp.Market Volume Report & Safe Swing Trade Setups - newser.com
How Pasithea Therapeutics Corp. Equity Warrant stock trades during market volatilityMarket Volume Summary & Weekly High Conviction Ideas - newser.com
Real time breakdown of Pasithea Therapeutics Corp. stock performanceJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - newser.com
Multi asset correlation models including Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Reactions & Long-Term Growth Plans - newser.com
How currency fluctuations impact Pasithea Therapeutics Corp. stock2025 Biggest Moves & Verified Entry Point Signals - newser.com
Has Pasithea Therapeutics Corp. Equity Warrant found a price floorJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com
How Pasithea Therapeutics Corp. stock responds to policy changesQuarterly Portfolio Review & Low Risk High Win Rate Picks - newser.com
Pasithea Therapeutics Corp.’s volatility index tracking explainedJuly 2025 Movers & Weekly Chart Analysis and Guides - newser.com
Using flow based indicators on Pasithea Therapeutics Corp.Portfolio Return Report & Low Drawdown Trading Techniques - newser.com
Pasithea Therapeutics Corp Stock Analysis and ForecastStock Buy Signals & Maximize Returns With Insights - earlytimes.in
What risks investors should watch in Pasithea Therapeutics Corp. stockPortfolio Update Summary & Safe Capital Investment Plans - newser.com
Is Pasithea Therapeutics Corp. forming a bottoming baseJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-10-10 08:53:04 - newser.com
Will a bounce in Pasithea Therapeutics Corp. offer an exitWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Short interest data insights for Pasithea Therapeutics Corp. Equity Warrant2025 Trade Ideas & Expert Verified Stock Movement Alerts - newser.com
Will Pasithea Therapeutics Corp. stock maintain dividend yield2025 Earnings Surprises & Weekly Return Optimization Alerts - newser.com
What moving averages say about Pasithea Therapeutics Corp.2025 Analyst Calls & Long-Term Safe Investment Plans - newser.com
Can Pasithea Therapeutics Corp. stock rebound after recent weakness2025 Trade Ideas & Weekly Momentum Picks - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock deliver strong dividend growthQuarterly Profit Review & Real-Time Stock Entry Alerts - newser.com
Published on: 2025-10-09 02:47:31 - newser.com
Pasithea Therapeutics Corp. stock daily chart insightsQuarterly Earnings Summary & Short-Term High Return Strategies - newser.com
Pasithea Therapeutics Corp Equity Warrant Stock Analysis and ForecastFederal Reserve Announcements & Get Tomorrow’s Winners Today With AI - earlytimes.in
What recovery options are there for Pasithea Therapeutics Corp.Product Launch & Free Community Supported Trade Ideas - newser.com
Pasithea Therapeutics Corp Azioni (KTTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pasithea Therapeutics Corp Azioni (KTTA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):